Aankondiging • Apr 24
TKG Huchems Co., Ltd. announced that it has received KRW 50 billion in funding from J&Alpha Co., Ltd On April 23, 2026, TKG Huchems Co., Ltd. has closed the transaction. Aankondiging • Apr 09
TKG Huchems Co., Ltd. announced that it expects to receive KRW 50 billion in funding from J&Alpha Co., Ltd TKG Huchems Co., Ltd. announced a private placement of series 4 unsecured privately placed exchangeable bond with bearer interest for gross proceeds of KRW 50,000,000,000 on April 8, 2026. The transaction will include participation from a new investor, J&Alpha Co., Ltd. for KRW 50,000,000,000. The bond has a maturity interest rate of 1% and will mature on April 23, 2031. The bonds are fully convertible into 2,819,283 common shares of the company at a conversion price of KRW 17,735 per share. The bonds can be converted between April 24, 2027 and March 23, 2031. The transaction is expected to close on April 23, 2026. The subscription date is April 23, 2026. The transaction has been approved by the board of directors of the company on April 8, 2026. Reported Earnings • Mar 24
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₩1,561 (down from ₩2,024 in FY 2024). Revenue: ₩1.13t (down 5.1% from FY 2024). Net income: ₩59.9b (down 23% from FY 2024). Profit margin: 5.3% (down from 6.5% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩16,900, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years. Aankondiging • Feb 27
TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026 TKG Huchems Co., Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea Price Target Changed • Feb 23
Price target decreased by 8.8% to ₩22,500 Down from ₩24,667, the current price target is an average from 2 analysts. New target price is 11% above last closing price of ₩20,350. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₩1,748 for next year compared to ₩2,024 last year. Upcoming Dividend • Feb 19
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 26 February 2026. Payment date: 24 April 2026. Payout ratio is a comfortable 56% and this is well supported by cash flows. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.2%). New Risk • Nov 24
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Price Target Changed • Mar 27
Price target decreased by 8.4% to ₩24,500 Down from ₩26,750, the current price target is an average from 2 analysts. New target price is 54% above last closing price of ₩15,950. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩2,115 for next year compared to ₩2,024 last year. New Risk • Mar 19
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.5% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.5% net profit margin). Reported Earnings • Mar 19
Full year 2024 earnings: EPS in line with analyst expectations despite revenue beat Full year 2024 results: EPS: ₩2,024 (down from ₩3,512 in FY 2023). Revenue: ₩1.19t (up 13% from FY 2023). Net income: ₩77.7b (down 42% from FY 2023). Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Aankondiging • Feb 21
TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025 TKG Huchems Co., Ltd., Annual General Meeting, Mar 21, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 173, toegye-ro, jung-gu, seoul South Korea Price Target Changed • Jan 01
Price target decreased by 8.5% to ₩26,750 Down from ₩29,250, the current price target is an average from 4 analysts. New target price is 57% above last closing price of ₩17,050. Stock is down 17% over the past year. The company is forecast to post earnings per share of ₩2,062 for next year compared to ₩3,512 last year. Upcoming Dividend • Dec 20
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Payout ratio is a comfortable 43% but the company is paying out more than the cash it is generating. Trailing yield: 5.4%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%). Aankondiging • Aug 28
TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion. TKG Huchems Co., Ltd. (KOSE:A069260) agreed to acquire 50% stake in JL Chem Co., Ltd. for KRW 60.3 billion on August 27, 2024. A cash consideration of KRW 60.33 billion will be paid by TKG Huchems for 502,721 shares. The expected completion of the transaction is August 28, 2024. Major Estimate Revision • Aug 23
Consensus EPS estimates fall by 13%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.17b to ₩1.23b. EPS estimate fell from ₩2,704 to ₩2,361 per share. Net income forecast to grow 4.9% next year vs 60% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩28,750 unchanged from last update. Share price was steady at ₩18,940 over the past week. Major Estimate Revision • Jul 23
Consensus EPS estimates fall by 13%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from ₩1.15b to ₩1.17b. EPS estimate fell from ₩2,716 to ₩2,356 per share. Net income forecast to shrink 19% next year vs 67% growth forecast for Chemicals industry in South Korea . Consensus price target broadly unchanged at ₩28,750. Share price was steady at ₩19,130 over the past week. New Risk • Jul 22
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.8% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Major Estimate Revision • Mar 06
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from ₩1.27b to ₩1.20b. EPS estimate also fell from ₩3,173 per share to ₩2,778 per share. Net income forecast to grow 32% next year vs 52% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩31,000 unchanged from last update. Share price was steady at ₩19,760 over the past week. Aankondiging • Feb 22
TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024 TKG Huchems Co., Ltd., Annual General Meeting, Mar 22, 2024, at 09:01 Korea Standard Time. Location: Namsan Square 19F, Toegyero 173, Junggu Seoul South Korea Agenda: To report Business Report, to consider audit Report; to consider Internal Accounting Control System Report; to consider approval of Financial Statements for the 22nd Term; to consider election of directors; to consider election of Executive Directors; to consider approval of ceiling amount for the remuneration onto Directors; and to consider approval of ceiling amount for the remuneration onto Auditor. Upcoming Dividend • Dec 20
Upcoming dividend of ₩1,000 per share at 4.4% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 4.4%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). New Risk • Oct 01
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Major Estimate Revision • May 25
Consensus revenue estimates decrease by 10%, EPS upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from ₩1.04b to ₩939.0m. EPS estimate increased from ₩2,449 to ₩2,939 per share. Net income forecast to grow 29% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩29,000 to ₩31,000. Share price was steady at ₩23,350 over the past week. Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩21,800, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 68% over the past three years. Major Estimate Revision • Jan 18
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₩1.21b to ₩1.23b. EPS estimate fell from ₩2,643 to ₩2,373 per share. Net income forecast to grow 25% next year vs 25% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩32,500 to ₩29,500. Share price was steady at ₩19,600 over the past week. Upcoming Dividend • Dec 21
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 48% and this is well supported by cash flows. Trailing yield: 4.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improved over the past week After last week's 17% share price gain to ₩23,400, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 24% over the past three years. Major Estimate Revision • Jul 15
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate fell from ₩3,370 to ₩2,842 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 46% next year vs 11% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩32,500 unchanged from last update. Share price fell 8.0% to ₩18,300 over the past week. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩1,000 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 59% and this is well supported by cash flows. Trailing yield: 4.3%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Price Target Changed • Dec 10
Price target increased to ₩30,750 Up from ₩27,750, the current price target is an average from 4 analysts. New target price is 29% above last closing price of ₩23,750. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of ₩2,281 for next year compared to ₩1,292 last year. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 16% share price gain to ₩27,450, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩31,191 per share. Major Estimate Revision • May 14
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 EPS estimate increased from ₩2,209 to ₩2,466. Revenue forecast steady at ₩772.0m. Net income forecast to grow 92% next year vs 87% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩27,750 unchanged from last update. Share price was steady at ₩21,900 over the past week. Reported Earnings • Mar 20
Full year 2020 earnings released: EPS ₩1,292 (vs ₩1,812 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩593.5b (down 10.0% from FY 2019). Net income: ₩49.6b (down 30% from FY 2019). Profit margin: 8.4% (down from 11% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 10
New 90-day low: ₩21,300 The company is down 11% from its price of ₩23,800 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,740 per share. Aankondiging • Feb 27
Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021 Huchems Fine Chemical Corporation, Annual General Meeting, Mar 26, 2021, at 09:00 Korea Standard Time. Major Estimate Revision • Feb 12
Analysts update estimates The 2020 consensus earning per share (EPS) estimate was lowered from ₩1,764 to ₩1,543. No change was made to the revenue estimate which at the last update was ₩590.1m. Net income is expected to grow by 72% next year compared to 60% growth forecast for the Chemicals industry in South Korea. The consensus price target of ₩30,000 was unchanged from the last update. Share price stayed mostly flat at ₩22,550 over the past week. Price Target Changed • Feb 03
Price target raised to ₩30,000 Up from ₩24,250, the current price target is an average from 2 analysts. The new target price is 28% above the current share price of ₩23,450. As of last close, the stock is up 22% over the past year. Is New 90 Day High Low • Jan 29
New 90-day low: ₩21,400 The company is down 7.0% from its price of ₩22,900 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩15,786 per share. Price Target Changed • Dec 30
Price target raised to ₩25,000 Up from ₩23,250, the current price target is an average from 3 analysts. The new target price is close to the current share price of ₩25,650. As of last close, the stock is up 21% over the past year. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩1,000 Per Share Will be paid on the 24th of April to those who are registered shareholders by the 29th of December. The trailing yield of 4.1% is in the top quartile of South Korean dividend payers (2.6%), and it is higher than industry peers (0.9%). Major Estimate Revision • Nov 12
Analysts lower revenue estimates to ₩585.8m The 2020 consensus revenue estimate decreased from ₩675.0m. Earning per share (EPS) estimate was also lowered from ₩1,915 to ₩1,792 for the same period. Net income is expected to grow by 24% next year compared to 40% growth forecast for the Chemicals industry in South Korea. The consensus price target increased from ₩23,250 to ₩24,250. Share price is up 8.5% to ₩24,900 over the past week. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 20% share price gain to ₩25,900, the stock is trading at a trailing P/E ratio of 16x, up from the previous P/E ratio of 13.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 25%. Price Target Changed • Nov 10
Price target raised to ₩24,250 Up from ₩21,900, the current price target is an average from 4 analysts. The new target price is 6.9% below the current share price of ₩26,050. As of last close, the stock is up 16% over the past year. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 17% share price gain to ₩27,150, the stock is trading at a trailing P/E ratio of 16.7x, up from the previous P/E ratio of 14.3x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 34%. Is New 90 Day High Low • Nov 09
New 90-day high: ₩27,150 The company is up 66% from its price of ₩16,400 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₩13,972 per share.